<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04268732</url>
  </required_header>
  <id_info>
    <org_study_id>1284/19</org_study_id>
    <nct_id>NCT04268732</nct_id>
  </id_info>
  <brief_title>Acute Undifferentiated Fever in Ethiopia</brief_title>
  <official_title>Causes of Acute Undifferentiated Fever and the Utility of Biomarkers in Differentiating Bacterial From Viral Infection Among Acute Febrile Patients in Northwest Ethiopia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Tropical Medicine, Belgium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Gondar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institute of Tropical Medicine, Belgium</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cross-sectional study on acute undifferentiated fever and the utility of biomarkers in
      differentiating bacterial from viral infection among acute febrile patients in Gondar,
      northwest Ethiopia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      General objective:

      To assess the causes of acute undifferentiated febrile illness and evaluation of biomarkers
      for differentiation of bacterial and viral infections among outpatients at University of
      Gondar (UOG) Hospital, Northwest Ethiopia

      Specific objectives

        1. To determine the number of malaria cases, bacterial infections (by blood culture and
           polymearase chain reaction (PCR) for Rickettsia and Borrelia), and arboviral infections
           (DENV, YFV, CHIKV) among all acute febrile patients

        2. To evaluate the diagnostic performance different assays (RDT, RT-(reverse
           transcriptase)PCR, ELISA) for the diagnosis of DENV

        3. To evaluate the qualitative detection of C-reactive protein (CRP) and Myxovirus
           resistance protein (MxA) (by FebriDx RDT) and quantitative CRP detection for
           differentiating bacterial and viral infections

      Study design, population, materials and methods: a cross-sectional cohort study on febrile
      patients presenting with acute fever at the emergency ward of the UOG hospital from June to
      August 2019. Clinical and epidemiological data will be recorded in a pseudo-anonymized and
      collected using an electronic data collection tool (KoBoToolbox). Blood will be collected for
      RDT testing, blood culture, PCR and serum for ELISA and RT-PCR.

      Sample size: 200 acute febrile patients

      Expected results and relevance: Evaluation of the causes of acute febrile illness and the
      role of biomarkers in differentiating viral and bacterial infections will increase the
      awareness of circulating pathogens and improve patient management. This evidence will
      contribute to a more rational use of laboratory diagnostic tests, antibiotics and
      antimalarial treatment.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">August 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The differentiation of bacterial infections and viral infections among acute febrile patients with biomarkers</measure>
    <time_frame>within 7 days after onset of fever</time_frame>
    <description>CRP (bacterial biomarker) and MxA (viral biomarker) will be evaluated for differentiating confirmed bacterial and viral infections.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The number of malaria cases, bacterial infections, viral infections and unknown etiologies among acute febrile patients in Gondar</measure>
    <time_frame>within 7 days after onset of fever</time_frame>
    <description>Different diagnostic tools will be used for analysis of acute febrile patient samples to confirm malaria (by RDT), bacterial infection (by blood culture and PCR for Rickettsia and Borrelia) and for viral infections (by RT-PCR for DENV, CHIKV, YFV). Samples negative for all these tests are defined as unknown etiology.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The comparison of different assays for diagnosis of DENV</measure>
    <time_frame>within 7 days after onset of fever</time_frame>
    <description>Different diagnostic tests will be evaluated for the detection of acute DENV infection (NS1 RDT, RT-PCR, ELISA IgM) and past DENV infection (ELISA IgG) among acute febrile patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The comparison of the qualitative and qualitative detection of CRP for differentiating bacterial and viral infections</measure>
    <time_frame>within 7 days after onset of fever</time_frame>
    <description>Qualitative CRP levels will be measured by FebriDx test and quantitative CRP levels will be measured by QuikReadGo. The detection of &gt; 20mg/L CRP will be used to evaluate the confirmed bacterial infections and to compare with antibiotic treatment.</description>
  </secondary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Acute Febrile Illness</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood serum blood culture bottles
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients ≥ 15 years old with acute undifferentiated fever and seeking health services
        within 7 days after fever onset at the emergency ward of the university of Gondar hospital
        (Ethiopia) during the study period.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting with acute fever (an axillary temperature of ≥37.5°C; symptom
             duration ≤7 days)

          -  ≥ 15 years old

          -  signed informed consent

        Exclusion Criteria:

          -  pregnant woman &amp; children (&lt;15 y)

          -  febrile patient suspected of urinary tract infection or acute respiratory tract
             infection

          -  Individuals who had taken antimicrobial and antimalarial drug in the last 2 weeks

          -  Patients with acute injury or trauma or for which participation in the study implies
             an unacceptable health risk as determined by the physicians
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Johan van Griensven, PhD, MD</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Tropical Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Tropical Medicine</name>
      <address>
        <city>Antwerp</city>
        <zip>2000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Gondar</name>
      <address>
        <city>Gondar</city>
        <country>Ethiopia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Ethiopia</country>
  </location_countries>
  <reference>
    <citation>Bhargava A, Ralph R, Chatterjee B, Bottieau E. Assessment and initial management of acute undifferentiated fever in tropical and subtropical regions. BMJ. 2018 Nov 29;363:k4766. doi: 10.1136/bmj.k4766.</citation>
    <PMID>30498133</PMID>
  </reference>
  <reference>
    <citation>Mohammed Yusuf A, Abdurashid Ibrahim N. Knowledge, attitude and practice towards dengue fever prevention and associated factors among public health sector health-care professionals: in Dire Dawa, eastern Ethiopia. Risk Manag Healthc Policy. 2019 Jun 7;12:91-104. doi: 10.2147/RMHP.S195214. eCollection 2019.</citation>
    <PMID>31239796</PMID>
  </reference>
  <reference>
    <citation>Ferede G, Tiruneh M, Abate E, Wondimeneh Y, Damtie D, Gadisa E, Howe R, Aseffa A, Tessema B. A serologic study of dengue in northwest Ethiopia: Suggesting preventive and control measures. PLoS Negl Trop Dis. 2018 May 31;12(5):e0006430. doi: 10.1371/journal.pntd.0006430. eCollection 2018 May.</citation>
    <PMID>29852020</PMID>
  </reference>
  <reference>
    <citation>Lilay A, Asamene N, Bekele A, Mengesha M, Wendabeku M, Tareke I, Girmay A, Wuletaw Y, Adossa A, Ba Y, Sall A, Jima D, Mengesha D. Reemergence of yellow fever in Ethiopia after 50 years, 2013: epidemiological and entomological investigations. BMC Infect Dis. 2017 May 15;17(1):343. doi: 10.1186/s12879-017-2435-4.</citation>
    <PMID>28506254</PMID>
  </reference>
  <reference>
    <citation>Animut A, Mekonnen Y, Shimelis D, Ephraim E. Febrile illnesses of different etiology among outpatients in four health centers in Northwestern Ethiopia. Jpn J Infect Dis. 2009 Mar;62(2):107-10.</citation>
    <PMID>19305049</PMID>
  </reference>
  <reference>
    <citation>Kapasi AJ, Dittrich S, González IJ, Rodwell TC. Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review. PLoS One. 2016 Aug 3;11(8):e0160278. doi: 10.1371/journal.pone.0160278. eCollection 2016. Review.</citation>
    <PMID>27486746</PMID>
  </reference>
  <reference>
    <citation>Self WH, Rosen J, Sharp SC, Filbin MR, Hou PC, Parekh AD, Kurz MC, Shapiro NI. Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections. J Clin Med. 2017 Oct 7;6(10). pii: E94. doi: 10.3390/jcm6100094.</citation>
    <PMID>28991170</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 11, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <last_update_submitted>February 14, 2020</last_update_submitted>
  <last_update_submitted_qc>February 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>biomarkers</keyword>
  <keyword>bacterial infection</keyword>
  <keyword>viral infection</keyword>
  <keyword>malarial infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

